TGen Working To Reduce Drug-Resistant Tuberculosis

Published: Friday, October 13, 2017 - 3:14pm
Updated: Friday, October 13, 2017 - 3:24pm
Audio icon Download mp3 (8.55 MB)

Physicians and researchers have been trying to defeat TB for centuries.

And new research from the Translational Genomics Research Institute, or TGen, suggests there’s promise in preventing patients from developing a resistance to tuberculosis drugs.

With me to explain is Dr. David Engelthaler, co-director of TGen’s Pathogen Genomics Division.

If you like this story, Donate Now!